Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Inhibitors (4)

Isotope-Labeled Compounds Related Products (10873):

Cat. No.	Product Name	Effect	Purity	Chemical Structure

HY-B0174AS3

Olsalazine-d₆
Olsalazine-d₆ is the deuterium labeled Olsalazine (HY-B0174A). Olsalazine is an orally active prodrug of 5-ASA (HY-15027). Olsalazine can inhibit cells proliferation and induce apoptosis. Olsalazine can reduce DAI and MPO activity and inhibit inflammatory cytokines levels. Olsalazine can be used for the researches of cancer, inflammation and metabolic disease, such as colorectal cancer, inflammatory bowel disease (IBD) and hyperuricemic.

HY-50878AS

Crizotinib-d₉ hydrochloride
Crizotinib-d₉ hydrochloride is deuterated labeled Crizotinib hydrochloride (HY-50878A). Crizotinib hydrochloride (PF-02341066 hydrochloride) is an orally bioavailable, selective, and ATP-competitive dual ALK and c-Met inhibitor with IC₅₀s of 20 and 8 nM, respectively. Crizotinib hydrochloride (PF-02341066 hydrochloride) inhibits tyrosine phosphorylation of NPM-ALK and tyrosine phosphorylation of c-Met with IC₅₀s of 24 and 11 nM in cell-based assays, respectively. It is also a ROS proto-oncogene 1 (ROS1) inhibitor. Crizotinib hydrochloride (PF-02341066 hydrochloride) has effective tumor growth inhibition.

HY-W720915

n-Dodecylbenzene-d₅
N-Dodecylbenzene-d₅ (1-Dodecylbenzene-d₅; 1-Phenyl-n-dodecane-d₅; 1-Phenyldodecane-d₅) is the deuterium labeled N-Dodecylbenzene (HY-Y1052).

HY-139808S

(±)-cis-N-Desmethylsertraline-d₃ hydrochloride
(±)-cis-N-Desmethylsertraline-d₃ (hydrochloride) is the deuterium labeled (±)-cis-N-Desmethylsertraline hydrochloride.

HY-118126S

Mecoprop-d₃
Mecoprop-d₃ is deuterium labeled Mecoprop.

HY-W704105

5-Methyltetraphene-d₁₄
5-Methyltetraphene-d₁₄ (5-Methylbenz[a]anthracene-d₁₄) is the deuterium labeled 5-Methyltetraphene.

HY-150672S

Tetra-O-acetyl-β-D-glucopyranosylvanilin-d₃
Tetra-O-acetyl-β-D-glucopyranosylvanilin-d₃ is the deuterium labeled Tetra-O-acetyl-β-D-glucopyranosylvanilin.

HY-W056964S

Naphthalene-2,6-dicarboxylic acid-d₆
Naphthalene-2,6-dicarboxylic acid-d₆ is the deuterium labeled Naphthalene-2,6-dicarboxylic acid.

HY-W654206

D-Glucose 6-Phosphate Sodium Salt Hydrate-¹³C₆
D-Glucose 6-Phosphate Sodium Salt Hydrate-¹³C₆ is the ¹³C-labeled D-Glucose 6-Phosphate Sodium Salt Hydrate.

HY-10466S

Daclatasvir-d₆		99.64%
Daclatasvir-d₆ is deuterium labeled Daclatasvir. Daclatasvir (BMS-790052) is a potent and orally active HCV NS5A protein inhibitor with EC₅₀s range of 9-146 pM for multiple HCV replicon genotypes. Daclatasvir is also a organic anion transporting polypeptide 1B (OATP1B) and OATP1B3 inhibitor with IC₅₀s of 1.5 μM and 3.27 μM, respectively.

HY-143798S

R (-) Tolperisone-d₁₀
R (-) Tolperisone-d₁₀ is the deuterium labeled R (-) Tolperisone.

HY-W416548S

1-Methyl-4-nitro piperazine-d₁₁
1-Methyl-4-nitro piperazine-d₁₁ is the deuterium labeled 1-Methyl-4-nitro piperazine. 1-Methyl-4-nitrosopiperazine (MNP; MeNP;N-Methyl-N'-nitrosopiperazine) is a potential impurity in sartans, non-steroidal anti-inflammatory drugs (NSAIDs), and thiazide diuretics.

HY-B1973S

Diflubenzuron-d₄
Diflubenzuron-d₄ is the deuterium labeled Diflubenzuron. Diflubenzuron is an insecticide with larvicidal and ovicidal activities. Diflubenzuron can inhibit the synthesis of chitin in insects, affect insect molting and lead to the death of insects.

HY-144571S

Trimethyl phloroglucinol-d₉
Trimethyl phloroglucinol-d₉ is the deuterium labeled Trimethyl phloroglucinol.

HY-132461S1

2-Hydroxy Desipramine-d₆
2-Hydroxy Desipramine-d₆ is the deuterium labeled 2-Hydroxy Desipramine.

HY-W094751S

1-Pyrenamin-d₉
1-Pyrenamin-d₉ is the deuterium labeled 1-Pyrenamin.

HY-B1899BS

Taurodeoxycholic acid-d₄-1 sodium
Taurodeoxycholic acid-d₄ (sodium) is the deuterium labeled Taurodeoxycholic acid.

HY-W018789S

3-Chloro-N,N-dimethylpropan-1-amine-d₆ hydrochloride		99%
3-Chloro-N,N-dimethylpropan-1-amine-d₆ (hydrochloride) is the deuterium labeled 3-Chloro-N,N-dimethylpropan-1-amine hydrochloride.

HY-W011090S

((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate-¹³C₉,¹⁵N₃ sodium
((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate-¹³C₉,¹⁵N₃ (sodium) is the ¹³C and ¹⁵N labeled Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate.

HY-116152S

Cipepofol-d₆
Cipepofol-d₆ (Ciprofol-d₆; HSK3486-d₆) is deuterium labeled Cipepofol (HY-116152). Cipepofol (HSK3486), a psychomotor stabilizing agent, is a gamma-aminobutyric acid (GABA) receptor potentiator.

Name
Email *

	Sorry, but the email address you supplied was invalid.